Brighton Park Capital: The $4.5B Growth Equity Firm Built for Profitable Scaling

Brighton Park Capital: The $4.5B Growth Equity Firm Built for Profitable Scaling

TL;DR: Brighton Park Capital is a Greenwich-based growth equity firm managing $4.481 billion in regulatory assets. It targets software, healthcare tech, and tech-enabled services companies already generating revenue. The firm takes minority or growth stakes, not control positions, and backs founders through scale. For accredited investors, Brighton Park represents a direct window into a specific and historically overlooked segment of private markets: profitable companies that need capital to grow, not capital to survive.

What the SEC Filing Actually Says

According to Brighton Park Capital's SEC Form ADV filing (CRD 304261, filed March 31, 2026), the firm manages $4.481 billion in regulatory assets. That number, $4,481,709,182 to be exact, comes directly from the firm's regulatory disclosure, not a marketing deck. It reflects capital committed across Brighton Park's fund vehicles, primarily Fund I (closed November 2020 at approximately $835 million) and Fund II (closed November 2022 at $1.8 billion, exceeding its $1.5 billion target). The SEC-verified figure tells you something important: Brighton Park grew from zero to $4.5 billion in roughly five years, during one of the most volatile stretches in technology investing on record.

The Fund II close deserves attention. Brighton Park hit its final close in November 2022, the same month public SaaS multiples were cratering and software valuations were falling 60 to 80 percent from peak. The firm raised $300 million above target in that environment. Institutional allocators don't do that unless they have conviction built on track record, not promises.

The Founder: Mark F. Dzialga

Brighton Park Capital was founded in 2019 by Mark F. Dzialga, who spent more than 20 years at General Atlantic before starting the firm. At General Atlantic, Dzialga served on the Executive Committee, the Portfolio Committee, and the Human Resources Committee. He chaired the firm's Investment Committee from 2007 through 2017. Before General Atlantic, he co-headed the High Technology Merger Group at Goldman Sachs.

Dzialga did not leave General Atlantic to start a different kind of firm. He left to build a more focused version of the same thesis: back exceptional growth-stage software and technology companies, stay close to the operators, and don't dilute attention by investing in 100 companies at once. The firm's stated principle is "Undivided Attention. True Investment." That phrase reflects the orientation directly.

The current partner roster includes Mike Gregoire, Sam Kentor, Kevin Magan, and Jeff Surges, alongside a bench of operating partners and senior advisors that includes former executives from Cisco, Workday, Snowflake, GE Capital, and Amazon Web Services. That advisor network is not decoration. It gives portfolio companies direct access to the people who built and operated the enterprise systems those companies are trying to displace or enhance.

What Growth Equity Actually Is

Growth equity occupies a specific position in the capital markets spectrum. It is not venture capital. It is not a leveraged buyout. Understanding the difference matters if you want to evaluate this asset class intelligently.

Venture capital funds companies at their earliest, most uncertain stages. A typical Series A or B round goes into a company with unproven product-market fit, limited revenue, and a long runway before profitability. The return profile reflects that risk: most early-stage bets fail, and a few return multiples that offset the losses. Brighton Park does not operate there.

Leveraged buyout firms take a different approach. They typically acquire majority or full control of mature businesses using significant debt. The return mechanism depends on financial engineering, cost reduction, and debt paydown as much as organic revenue growth. Brighton Park does not operate there either.

Growth equity sits between those two endpoints. The target company already has revenue. Brighton Park focuses on businesses in the $50 million to $500 million revenue range. The product works. Customers are paying recurring fees. What the company needs is capital to expand sales, enter new geographies, build out product, or acquire complementary businesses. Brighton Park writes checks between $50 million and $250 million to fund that expansion, typically as a minority or meaningful growth stake without requiring a change-of-control transaction.

The risk profile differs from both venture and buyout. You are not betting on whether the product works. You already know it works. You are betting on whether the company can execute at scale. That is a narrower, more quantifiable question, which is why growth equity has attracted increasing allocations from institutional investors seeking technology exposure without the binary risk of early-stage venture.

The Portfolio: What Brighton Park Actually Owns

Brighton Park's current portfolio spans roughly 25 active companies across software and healthcare. The software side includes Silverfort (identity security, zero-trust architecture), PortSwigger (application security testing used by professional penetration testers), Coralogix (observability platform for modern software teams), HITRUST (cybersecurity and compliance certification for healthcare and enterprise), and TickPick — a no-fee live event ticketing marketplace with approximately $1 billion in annual ticket sales when Brighton Park invested $250 million in August 2024, the largest fundraise in ticketing industry history at the time.

On the healthcare side, the firm holds Xsolis (AI-driven automation of administrative tasks in hospital systems), Relatient (patient scheduling and engagement), and Person Centred Software (clinical system-of-record software for elderly care). Tech-enabled services holdings include MathCo and HTEC, both focused on data analytics and enterprise digital transformation.

Recent additions show where Brighton Park is placing new bets: Orca AI ($72.5 million Series B, May 2025) for AI-powered ship navigation, Canary Technologies ($80 million, June 2025) for AI-native hospitality software, and ORO Labs (March 2026) for procurement orchestration. The pattern is consistent. Each company is already operating in a defined market with real customers. None are speculative pre-revenue bets.

The Exits: Where Returns Come From

Brighton Park has five portfolio exits. Two stand out.

Paradox, the conversational AI platform for high-volume hiring, was acquired by Workday for $1 billion in cash in August 2025. Brighton Park partner Mike Gregoire served on the board throughout the hold period. That exit represents the clearest signal of how Brighton Park creates value: back a proven product in a large market, help the company scale its sales motion and expand its customer base, then exit when a strategic acquirer decides the asset is worth a billion dollars.

NuORDER, a B2B wholesale commerce platform, was acquired by Lightspeed for $425 million in 2021. Brighton Park invested approximately six months before that acquisition offer arrived. That compressed hold period produced a rapid return for Fund I.

Darktrace went public on the London Stock Exchange in April 2021. Indegene, a pharmaceutical commercialization platform in which Brighton Park and Carlyle jointly took a $200 million minority stake in 2021, had its Indian IPO oversubscribed 70.3 times.

Four exits above $200 million from a firm that did not exist before 2019. That is a credible early track record. It is not proof of future results. But it establishes that the team knows how to source, structure, and exit growth equity deals at scale.

The Founder-Friendly Claim: Is It Real?

Brighton Park has been named to Inc.'s Founder-Friendly Investors list for four consecutive years, 2022 through 2025. Inc. compiles this list by surveying founders who have actually worked with the firms, not by asking the firms to nominate themselves.

The minority-stake model is part of why founders respond positively. When Brighton Park invests, the founding team keeps control. The capital goes to work on growth, not on servicing acquisition debt. The firm's investment professionals, several of whom built and sold companies before joining Brighton Park, sit alongside founders as partners rather than overseers. That distinction matters to operators who have built something and don't want to hand over the keys to a financial buyer.

Brighton Park's London office, opened in July 2025 and led by Tom Hussey, extends that model into European markets. Fifty-three percent of the firm's portfolio companies have already established global operations. The London presence helps Brighton Park source European deals and support portfolio companies expanding across the Atlantic.

What This Means for Accredited Investors

Brighton Park Capital does not accept retail investment. The firm raises capital from institutional limited partners: endowments, pension funds, family offices, and sovereign wealth funds. Minimum LP commitments in vehicles like Brighton Park's typically start at $5 million to $10 million. You cannot buy Brighton Park on a brokerage platform.

That said, accredited investors have real options for growth equity exposure. Secondary market platforms including EquityZen and Forge allow accredited investors to purchase secondary stakes in private funds or portfolio companies, sometimes at discounts to NAV when existing holders need liquidity. Interval funds and business development companies with growth equity mandates offer another route, though they carry their own fee structures and liquidity constraints. Some registered investment advisors with private market access can allocate client capital into feeder vehicles with lower minimums.

None of these paths are equivalent to being a direct LP in a Brighton Park fund. But they give sophisticated accredited investors meaningful exposure to the same asset class the firm represents: revenue-generating, scaling technology companies in the gap between venture-backed startups and public market maturity.

One risk worth naming directly: growth equity valuations are not immune to market cycles. Fund II closed at the depth of a software selloff, which likely meant Brighton Park entered many 2022 to 2023 investments at more attractive prices than the 2021 peak. If you are looking at this asset class today, valuations in software and healthcare technology are recovering. Entry multiples matter. Understand what you're paying before you commit capital.

The Bottom Line

Brighton Park Capital is a focused firm. It manages $4.481 billion in SEC-verified regulatory assets, built in five years by a team with deep roots at General Atlantic and Goldman Sachs. It invests in a specific slice of private markets: software and healthcare technology companies that are already working, already generating revenue, and need capital to scale. It takes minority stakes, stays close to operators, and exits through acquisitions and public offerings.

That is not a promise of returns. Growth equity carries real risk. Companies that look like clear winners at the growth stage still fail to reach scale. Markets shift. Acquirers walk away from deals. Public market windows close.

What Brighton Park offers is a disciplined, specific thesis executed by a team that has done this before at much larger scale. For the asset class as a whole, and for understanding where private capital is flowing in technology, the firm is worth studying carefully.

Author Disclosure: Jeff Barnes, MBA has no personal position in any company, fund, or platform named in this article. Angel Investors Network has no current commercial relationship with any party mentioned. AIN provides marketing and education services, not investment advice. Past performance does not guarantee future results. All investments involve risk, including loss of principal.